Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01096589 · ClinicalTrials.gov registry record · NA
Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage
A NA study, sponsored by Solventum US.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT01096589 is a NA study that has completed, run by Solventum US. The registered enrollment target is 82 participants.
The verdict
NCT01096589, a NA study, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
Objectives. The primary objective of the study is to assess volume reduction in the treatment of lymphoedematous legs and arms with compression bandaging. Secondary objectives: * Assessment of safety * Quality of life * Health economic parameters * Slippage * Subbandage pressure
Interventions
- DEVICE 3M Coban 2 (Compression System)
- DEVICE Comprilan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01096589
The ClinicalTrials.gov registry entry for NCT01096589 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 3M Coban 2 (Compression System) is the first listed.
NCT01096589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01096589 about?
NCT01096589 is a clinical study titled "Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage". Objectives. The primary objective of the study is to assess volume reduction in the treatment of lymphoedematous legs and arms with compression bandaging. Secondary objectives: * Assessment of safety * Quality of life * Health economic parameters * Slippage * Subbandage pressure
What is the current status of trial NCT01096589?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2010-03. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01096589?
The interventions under investigation include: 3M Coban 2 (Compression System) (DEVICE), Comprilan (DEVICE).
Who is sponsoring clinical trial NCT01096589?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.